Form DFRN14A - Revised definitive proxy statement filed by non-management:
SEC Accession No. 0000903423-01-500033
Filing Date
2001-05-02
Accepted
2001-05-02 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 icn889341-3.txt DFRN14A 90236
  Complete submission text file 0000903423-01-500033.txt   92018
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
ICN PHARMACEUTICALS INC (Subject) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFRN14A | Act: 34 | File No.: 001-11397 | Film No.: 1619608
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 730 FIFTH AVENUE NEW YORK NY 10019
ICN COMMITTEE TO MAXIMIZE SHAREHOLDER VALUE (Filed by) CIK: 0001137668 (see all company filings)